James F. Oliviero III - 31 Mar 2023 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
CEO, President and Director, Director
Signature
/s/ James F. Oliviero, III
Issuer symbol
CKPT
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:30:59 UTC
Previous filing
03 Mar 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK (RESTRICTED) Award $0 +250,000 +174% $0.000000 394,090 31 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of restricted stock vest as follows: one-fourth on March 31, 2024, one-fourth on March 31, 2025, one-fourth on March 31, 2026 and one-fourth on March 31, 2027.
F2 Includes shares of restricted common stock, which vest over various time periods.